JULÄINE™
Introducing JULÄINE™ Of Sweden, a next generation collagen bio-activator
JULÄINE™ by Nordberg Medical, a next generation PLLA-based (poly-L-lactic acid) dermal bio-activator that has potential to become the go-to treatment for the most discerning medical aesthetic patients across Europe. Designed with Nordberg Medical’s unique LaSynProTM (Lactic-Acid Induced Synthesis of Collagen Protein) biomaterial-microsphere technology, JULÄINE™ stimulates collagen in a low-inflammatory way, attracting fibroblasts (the essential cells responsible for collagen production) and restoring skin’s natural, healthy function.
By upregulating the skin’s healthy function – namely the Extra Cellular Matrix (ECM) that is responsible for fibroblast activation and collagen production – JULÄINE™ delivers significant improvements on the key signs of skin ageing such as skin laxity and fine lines.
With its low-inflammatory mechanism and ability to deliver natural and long-lasting results, JULÄINE™ offers a new standard for patients that want to support long-term skin health and is set to become a cornerstone treatment in the future of regenerative aesthetics.
